 | Up a level |
Hoshino, Takao; Sissani, Leila; Labreuche, Julien; Bousser, Marie-Germaine; Chamorro, Angel; Fisher, Marc; Ford, Ian; Fox, Kim M; Hennerici, Michael G; Mattle, Heinrich; Rothwell, Peter M; Gabriel Steg, Philippe; Vicaut, Eric; Amarenco, Pierre (2019). Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study. European stroke journal, 4(1), pp. 65-74. Sage 10.1177/2396987318797245
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). New prospects for PCSK9 inhibition? European Heart Journal, 39(27), pp. 2600-2601. Oxford University Press 10.1093/eurheartj/ehy147
Landmesser, Ulf; Chapman, M John; Stock, Jane K; Amarenco, Pierre; Belch, Jill J F; Borén, Jan; Farnier, Michel; Ference, Brian A; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E; Hovingh, G Kees; Lüscher, Thomas F; Piepoli, Massimo F; Ray, Kausik K; Stroes, Erik S; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; ... (2018). 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. European Heart Journal, 39(14), pp. 1131-1143. Oxford University Press 10.1093/eurheartj/ehx549
Hilkens, Nina A; Algra, Ale; Diener, Hans-Christoph; Reitsma, Johannes B; Bath, Philip M; Csiba, Laszlo; Hacke, Werner; Kappelle, L Jaap; Koudstaal, Peter J; Leys, Didier; Mas, Jean-Louis; Sacco, Ralph L; Amarenco, Pierre; Sissani, Leila; Greving, Jacoba P; Cerebrovascular Antiplatelet Trialists, Collaborative Group (2017). Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: STOP-BLEED. Neurology, 89(9), pp. 936-943. Lippincott Williams & Wilkins 10.1212/WNL.0000000000004289
Amarenco, Pierre; Sissani, Leila; Labreuche, Julien; Vicaut, Eric; Bousser, Marie Germaine; Chamorro, Angel; Fisher, Marc; Ford, Ian; Fox, Kim M; Hennerici, Michael G; Mattle, Heinrich; Rothwell, Peter M; Steg, Philippe Gabriel; Diener, Hans-Christoph; Sacco, Ralph L; Greving, Jacoba P; Algra, Ale (2017). The Intracranial-B2LEED3S Score and the Risk of Intracranial Hemorrhage in Ischemic Stroke Patients Under Antiplatelet Treatment. Cerebrovascular diseases, 43(3-4), pp. 145-151. Karger 10.1159/000453459
Abboud, Halim; Sissani, Leila; Labreuche, Julien; Arauz, Antonio; Bousser, Marie-Germaine; Bryer, Alain; Chamorro, Angel; Fisher, Marc; Ford, Ian; Fox, Kim M; Hennerici, Michael G; Lavados, Pablo M; Massaro, Ayrton; Mattle, Heinrich; Munoz Collazos, Mario; Rothwell, Peter M; Steg, Philippe Gabriel; Vicaut, Eric; Yamouth, Bassem and Amarenco, Pierre (2017). Specificities of Ischemic Stroke Risk Factors in Arab-Speaking Countries. Cerebrovascular diseases, 43(3-4), pp. 169-177. Karger 10.1159/000454776
Gonzalez-Valcarcel, Jaime; Sissani, Leila; Labreuche, Julien; Bousser, Marie-Germaine; Chamorro, Angel; Fisher, Marc; Ford, Ian; Fox, Kim M; Hennerici, Michael G; Mattle, Heinrich; Rothwell, Peter M; Steg, Philippe Gabriel; Vicaut, Eric; Amarenco, Pierre (2016). Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke. Stroke, 47(4), pp. 1045-1052. Lippincott Williams & Wilkins 10.1161/STROKEAHA.115.012091
Sirimarco, Gaia; Labreuche, Julien; Bruckert, Eric; Goldstein, Larry B; Fox, Kim M; Rothwell, Peter M; Amarenco, Pierre; Mattle, Heinrich P (2014). Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke, 45(5), pp. 1429-1436. Lippincott Williams & Wilkins 10.1161/STROKEAHA.113.004229
Lavallée, Philippa C.; Labreuche, Julien; Fox, Kim M.; Lavados, Pablo; Mattle, Heinrich; Steg, Philippe Gabriel; Amarenco, Pierre (2014). Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology, 82(21), pp. 1905-1913. Lippincott Williams & Wilkins 10.1212/WNL.0000000000000456
Fox, Kim; Bousser, Marie-Germaine; Amarenco, Pierre; Chamorro, Angel; Fisher, Marc; Ford, Ian; Hennerici, Michael G.; Mattle, Heinrich P.; Rothwell, Peter M. (2013). Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population. International journal of cardiology, 168(4), pp. 3500-3505. Elsevier 10.1016/j.ijcard.2013.04.206
Bousser, Marie-Germaine; Amarenco, Pierre; Chamorro, Angel; Fisher, Marc; Ford, Ian; Fox, Kim M; Hennerici, Michael G; Mattle, Heinrich P; Rothwell, Peter M; de Cordoüe, Agnès; Fratacci, Marie-Dominique; PERFORM Study Investigators, (2011). Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet, 377(9782), pp. 2013-22. London: Elsevier 10.1016/S0140-6736(11)60600-4
Meairs, Stephen; Wahlgren, Nils; Dirnagl, Ulrich; Lindvall, Olle; Rothwell, Peter; Baron, Jean-Claude; Hossmann, Konstantin; Engelhardt, Britta; Ferro, José; McCulloch, James; Kaste, Markku; Endres, Matthias; Koistinaho, Jari; Planas, Anna; Vivien, Denis; Dijkhuizen, Rick; Czlonkowska, Anna; Hagen, Arne; Evans, Alan; De Libero, Gennaro; ... (2006). Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovascular diseases, 22(2-3), pp. 75-82. Basel: Karger 10.1159/000093098
